goralatide has been researched along with Invasiveness, Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abali, H; Engin, H; Erman, M; Güllü, IH; Haznedaroğlu, IC; Tekuzman, G | 1 |
1 other study(ies) available for goralatide and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Topics: Angiogenesis Inhibitors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Platelets; Carcinoma, Lewis Lung; Drug Evaluation, Preclinical; Endothelial Growth Factors; Hematopoiesis; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Oligopeptides; Platelet Activation; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |